Ishizawa Keisuke, Hirose Takanori, Sugiyama Kazuhiko, Kageji Teruyoshi, Nobusawa Sumihito, Homma Taku, Komori Takashi, Sasaki Atsushi
Department of Pathology, Saitama Medical University, Saitama, Japan.
Clin Neuropathol. 2012 Mar-Apr;31(2):67-76. doi: 10.5414/np300402.
Glioneuronal tumor with neuropil-like islands (GTNI) is featured by "neuropil-like islands (NIs)" within dominating astroglial components. Isocitrate dehydrogenase (IDH) mutations, particularly IDH1 R132H (G395A), are found in WHO Grade II and III diffuse gliomas as well as secondary, but not primary, glioblastomas. We reviewed 5 cases of GTNI, and assessed histology and immunohistochemistry with various antibodies, including those for IDH1 R132H, as well as direct DNA sequencing for IDH1 G395A. NIs were variable in morphology, and constantly synaptophysin-positive and glial fibrillary acidic protein-negative. The glioma components were primary glioblastoma in 2 cases, anaplastic astrocytoma in 1 and anaplastic oligoastrocytoma in 2. The IDH1 R132H was expressed in the 2 cases with oligoastrocytoma: In 1, NIs and the astrocytoma-like area as well as the oligodendroglioma-like area were positive. In the other, only the oligodendrogliomalike area was positive. The mutation analysis performed on the latter case with DNA separately sampled from the oligodendroglioma- like area and the astrocytoma-like area detected IDH1 G395A in both areas. We have shown diverse pathologic aspects of GTNI. Also, we have shown that the expression of IDH1 R132H in GTNI is largely concordant with that in diffuse gliomas, and that it can be dependent on each histologic component although the mutant IDH1 gene is ubiquitously present within the tumor.
伴有神经毡样岛的神经胶质神经元肿瘤(GTNI)的特征是在主要的星形胶质细胞成分中存在“神经毡样岛(NIs)”。异柠檬酸脱氢酶(IDH)突变,特别是IDH1 R132H(G395A),见于世界卫生组织二级和三级弥漫性胶质瘤以及继发性(而非原发性)胶质母细胞瘤。我们回顾了5例GTNI病例,并使用多种抗体评估了组织学和免疫组化,包括针对IDH1 R132H的抗体,以及对IDH1 G395A进行直接DNA测序。NIs形态各异,始终突触素阳性且胶质纤维酸性蛋白阴性。胶质瘤成分中,2例为原发性胶质母细胞瘤,1例为间变性星形细胞瘤,2例为间变性少突星形细胞瘤。IDH1 R132H在2例少突星形细胞瘤中表达:其中1例,NIs、星形细胞瘤样区域以及少突胶质细胞瘤样区域均为阳性。另一例中,仅少突胶质细胞瘤样区域为阳性。对后一例分别从少突胶质细胞瘤样区域和星形细胞瘤样区域单独取样的DNA进行的突变分析在两个区域均检测到IDH1 G395A。我们展示了GTNI多样的病理表现。此外,我们还表明,GTNI中IDH1 R132H的表达与弥漫性胶质瘤中的表达基本一致,并且尽管突变的IDH1基因在肿瘤中普遍存在,但它可能取决于每个组织学成分。